Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 24, 2026
King's College London. "Plant-rich, low saturated-fat diet associated with reduced psoriasis severity." ScienceDaily. ScienceDaily, 21 February 2025. <www.sciencedaily.com/releases/2025/02/25022112...
May 24, 2026
A recent study has found an increase in the incidence of several early-onset cancers between 2010 and 2019. This trend suggests a growing public health concern.
May 24, 2026
American Association for Cancer Research. "Incidence of several early-onset cancers increased between 2010 and 2019." ScienceDaily. ScienceDaily, 8 May 2025. <www.sciencedaily.com/releases/2025/05/...
May 24, 2026
A recent study has found that the incidence of several early-onset cancers has increased between 2010 and 2019. This trend suggests a growing concern for public health.
May 24, 2026
A recent study has found micro-nano-plastics in arterial plaque in the neck, a common site for atherosclerosis. The discovery raises concerns about the potential impact of plastic pollution on cardiovascular health.
May 24, 2026
Researchers have discovered molecular glues that can protect insulin-producing cells from damage related to diabetes. These findings may lead to new treatments for diabetes and other metabolic disorders.
May 24, 2026
Researchers at Mount Sinai have identified molecular "glues" that shield insulin-producing cells from damage related to diabetes. These molecular glues may potentially help preserve pancreatic beta cell function and improve glucose regulation.
May 24, 2026
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes." ScienceDaily. ScienceDaily, 4 Ma...
May 24, 2026
Researchers at the Scripps Research Institute have made significant breakthroughs in enzyme engineering, paving the way for innovative treatments of diseases such as Parkinson's and various types of cancer. This groundbreaking research has opened up new possibilities for targeting protein-related disorders that are notoriously difficult to treat.
